stock
LITS · Lite Strategy, Inc.
Insiders net bought $12,550 in 90 days; last 8-K filed Nov 3: unregistered share sale.
Follow LITS freePrice
Loading the LITS chart…
Chart by TradingView
The business
What the company does and what it reports, from its SEC filings.
What it is
Lite Strategy, Inc. (Nasdaq: LITS) is a pharmaceutical company that has historically developed novel and differentiated cancer therapies. During fiscal year 2026, we commenced pre-clinical development programs in nononcologic disease indications. We also hold Litecoin (LTC) tokens as a primary reserve asset as part of our broader institutional treasury initiative. We initially built our pipeline by acquiring promising cancer agents and creating value in programs through clinical development, strategic partnerships, and out-licensing or commercialization, as appropriate. Our approach to pre-clinical drug development is to evaluate our drug candidates either as stand-alone or in combination with standard-of-care therapies to overcome known resistance mechanisms and address medical needs to provide improved patient benefit.
From the 10-K for the fiscal year ended Jun 30, 2026, filed Sep 28, 2026.
Read the 10-K on SEC- Sector
- Crypto Assets (SEC office)
- Industry
- Finance Services (SIC 6199)
- Employees
- Not stated in the 10-K.
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year ends
- June
- Exchange
- Nasdaq
- Fractional shares
- No
- Listed options
- Yes
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Formerly
- MEI Pharma, Inc. (until 2025); MARSHALL EDWARDS INC (until 2012)
- Shares outstanding
- 29,884,653 as of Oct 30, 2026 (XBRL frame )
- Filer (SEC EDGAR)
- EDGAR filing index
Key stats
Valuation and the ratios that use the live price are free with an account.
Start free to see thisDeep value
- NCAV
- $4.50M
- NCAV per share
- $0.15
- NNWC
- $2.58M
- NNWC per share
- $0.09
Expectations
- Free cash flow
- —
- Free cash growth, last 5 years
- —
- Revenue growth, last 5 years
- —
Margins
- Gross
- —
- Operating
- —
- Net
- —
Returns
- ROE
- -90.8%
- ROA
- -88.2%
Health
- Current ratio
- 3.6x
- Debt/equity
- —
Trailing twelve months to Sep 30, 2026; balance sheet at Sep 30, 2026.
Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| Sep 30, 2026 | — | —Gross profit: unreported by this company. | $14.52M | $16.02M | |
| Jun 30, 2026 | — | —Gross profit: unreported by this company. | -$11.36M | -$13.02M | Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| Mar 31, 2026 | — | —Gross profit: unreported by this company. | -$21.61M | -$23.69M | |
| Dec 31, 2025 | — | —Gross profit: unreported by this company. | -$29.87M | -$30.80M | Assembled from more than one filing; the filing above is only the newest of them. |
| Sep 30, 2025 | — | —Gross profit: unreported by this company. | -$3.74M | -$3.64M | |
| Jun 30, 2025 | $0 | —Gross profit: unreported by this company. | -$2.88M | -$2.69M | Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| Mar 31, 2025 | $0 | —Gross profit: unreported by this company. | -$2.77M | -$2.57M | Assembled from more than one filing; the filing above is only the newest of them. |
| Dec 31, 2024 | $0 | —Gross profit: unreported by this company. | -$3.45M | -$2.68M | Assembled from more than one filing; the filing above is only the newest of them. |
- Cash
- $4.28M
- Debt
- —
- Net cash
- —
- Current assets
- $6.20M
- Current liabilities
- $1.71M
- Working capital
- $4.50M
- Total liabilities
- $1.71M
- Assets
- $58.40M
- Equity
- $56.70M
Balance as of Sep 30, 2026.
SEC data as of Nov 17, 2026
Earnings moves
| Report | Reaction day |
|---|---|
| Jul 30, 2026 Before the open | Jul 30, 2026 |
| May 13, 2026 Before the open | May 13, 2026 |
| Feb 17, 2026 Before the open | Feb 17, 2026 |
How the price moved after each report: Start free to see this
What happened after past reports, not a forecast. Report dates from SEC 8-K results filings (Item 2.02) since Oct 6, 2025; moves from daily closes.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| Jun 30, 2026 | — | -$66.58M | -$71.15M | — |
| Jun 30, 2025 | $0 | -$17.45M | -$15.95M | -$20.84M |
| Jun 30, 2024 | $65.30M | $14.54M | $18.00M | -$50.48M |
| Jun 30, 2023 | $48.82M | -$36.76M | -$32.00M | -$52.52M |
| Jun 30, 2022 | $40.70M | -$75.48M | -$54.00M | -$49.23M |
| Jun 30, 2021 | $34.80M | -$60.42M | -$41.00M | -$32.67M |
| Jun 30, 2020 | $27.76M | -$25.70M | -$47.17M | $33.36M |
| Jun 30, 2019 | $4.92M | -$46.24M | -$16.82M | -$29.64M |
| Jun 30, 2018 | $1.62M | -$28.59M | -$40.07M | — |
| Jun 30, 2017 | $23.25M | $2.38M | $2.67M | $3.44M |
What it filed
Material events and 5% ownership filings from the last year.
Company filings
since Mon Sep 28
events
5% owners ()
Alexander Schornstein
Stake update
Citadel Advisors LLC
Stake update
Alexander Schornstein
Stake update
Owners and trading
Insider, politician and fund moves, short interest, and the volume traded off the exchange.
Insiders, politicians and funds
Insider trades, last 90 days
Glover Nicholas
Director
Buy$12,550Oct 26, 5:44 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
None of the tracked funds held this at their last 13F.
Short interest
Hard to borrow: Alpaca will not lend it for shorting
Shares short
118,875
Of shares outstanding
0.4%
Days to cover
1.0
Change since last report
+9.5%
Settlement date Oct 30, 2026
Off-exchange short volume, 20 days
36.2%
Through Nov 17, 2026
Of the volume reported to FINRA's off-exchange facilities, market makers' hedging included. It is not short interest.
Short interest and short volume: FINRA
Off-exchange and dark pools
About 57.5% of shares traded off the exchanges
Period ending Oct 30, 2026, FINRA
Week of Oct 12, 2026, published by FINRA 2 to 4 weeks later
- Dark pools (ATS)15.9%
- Wholesalers and other dealers84.1%
Venues, week of Oct 12, 2026
Top dark pools
- IATS IBKR ATS52,611
- INCR INTELLIGENT CROSS LLC15,853
- UBSA UBS ATS11,279
- SGMT SIGMA X29,361
- LATS THE BARCLAYS ATS7,270
This shows where shares traded, not who bought or sold. Most off-exchange volume is retail orders filled by wholesalers.
Source: FINRA
Members see
- Signals: which strategies fired on LITS, and the evidence behind each
- Options positioning: the levels dealers are hedged around
- Technicals: trend and momentum readings
- Earnings moves: how the price moved after each report
- News: stories counted once across outlets
nakagai
Signals on LITS come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Follow LITS free
Comments · 0
No comments yet.